GPT and metabolic dysfunction-associated steatohepatitis: The metabolomics-advanced steatohepatitis fibrosis (MASEF) score, integrating 12 lipids, BMI, AST, and ALT, could identify high-risk MASH patients and achieve an AUROC of 0.79 in the validation cohort, showing its potential to replace liver stiffness measurement and become part of the existing diagnostic algorithm [152].